Diastolic heart failure

被引：0
|
作者：
Wachter, R. [1 ,2 ]
机构：
[1] Univ Med Gottingen, Univ Gottingen, Klin Kardiol & Pneumol, D-37075 Gottingen, Germany
[2] Univ Med Gottingen, Univ Gottingen, Deutsch Zentrum Herz Kreislauf Forsch DZHK, D-37075 Gottingen, Germany
来源：
INTERNIST | 2014年 / 55卷 / 06期
关键词：
Diastolic dysfunction; Echocardiography; Aldosterone antagonists; Neprilysin; Ranolazine; PRESERVED EJECTION FRACTION; RANDOMIZED CONTROLLED-TRIAL; PHOSPHODIESTERASE-5; INHIBITION; EXERCISE CAPACITY;
D O I：
10.1007/s00108-013-3428-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure with preserved ejection fraction (i.e. diastolic heart failure) accounts for about half of heart failure cases. The aim of this review is to reflect current knowledge regarding the epidemiology, pathophysiology and treatment. Diastolic heart failure patients are principally elderly and predominantly female. Numerous pathophysiological alterations in this disease have been shown and recent therapeutic recommendations include control of cardiovascular risk factors and symptoms. New therapeutic options, such as inhibition of late sodium current, aldosterone receptor blockade, combined inhibition of AT1 receptor and the enzyme neprilysin, and phosphodiesterase 5 inhibition are discussed in this review and ongoing clinical trials are also briefly presented. Diastolic heart failure remains a cardiac disease which is difficult to treat; however, new study results allow a better definition of a population of patients who could benefit from specific therapies.
引用
收藏
页码：663 / 668
页数：6
相关论文
共 50 条
  • [21] DIASTOLIC HEART-FAILURE
    WHEELDON, NM
    CLARKSON, P
    MACDONALD, TM
    EUROPEAN HEART JOURNAL, 1994, 15 (12) : 1689 - 1697
  • [22] Diagnosis of diastolic heart failure
    Fukuta H.
    Little W.C.
    Current Cardiology Reports, 2007, 9 (3) : 224 - 228
  • [23] Diastolische HerzinsuffizienzDiastolic heart failure
    R. Wachter
    Der Internist, 2014, 55 (6): : 663 - 668
  • [24] Management of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction
    Kanwar, Manreet
    Tedford, Ryan J.
    Agarwal, Richa
    Clarke, Megan M.
    Walter, Claire
    Sokos, George
    Murali, Srinivas
    Benza, Raymond L.
    CURRENT HYPERTENSION REPORTS, 2014, 16 (12) : 1 - 9
  • [25] Neurohormonal activation and maximal exercise capacity in diastolic dysfunction and diastolic heart failure
    Edelmann, F.
    Duvinage, A.
    Schwarz, S.
    Stahrenberg, R.
    Wachter, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (16) : 810 - 815
  • [26] Hypertension and diastolic heart failure
    Gradman A.H.
    Travis Wilson J.
    Current Cardiology Reports, 2009, 11 (6) : 422 - 429
  • [27] Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial)
    Koller, B.
    Steringer-Mascherbauer, R.
    Ebner, C. H.
    Weber, Th.
    Ammer, M.
    Eichinger, J.
    Pretsch, I.
    Herold, M.
    Schwaiger, J.
    Ulmer, H.
    Grander, W.
    HEART LUNG AND CIRCULATION, 2017, 26 (05) : 433 - 441
  • [28] Heart failure with preserved ejection fraction (diastolic heart failure)
    Güder G.
    Ertl G.
    MMW - Fortschritte der Medizin, 2019, 161 (9) : 58 - 65
  • [29] Echocardiographic evaluation of diastolic dysfunction and diastolic heart failure
    Galderisi, Maurizio
    SALUD I CIENCIA, 2007, 15 (05): : 814 - 818
  • [30] Differential diagnosis and clinical management of diastolic heart failure: current best practice
    Tawil, Justin
    Gelzinis, Theresa A.
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2016, 7 : 117 - 135
12345